全体要約
ホスホイノシチド3キナーゼ阻害剤市場は、2022年の売上を基に、2023年から2029年までの予測を地域別および市場セクター別に分析しています。
アメリカ、中国、ヨーロッパの市場はそれぞれ成長が見込まれ、主要企業にはBayer AG、Gilead Sciences Inc.、Novartis AGなどが含まれ、2022年には上位2社が市場の大部分を占めています。
このレポートは、ホスホイノシチド3キナーゼ阻害剤の製品タイプ、アプリケーション、主要プレイヤー、地域別の市場シェアと成長機会を包括的に示しています。市場は、Pan-PI3K阻害剤、Dual PI3K/mTOR阻害剤、慢性リンパ性白血病などの適応症に分かれています。
関連する質問
Bayer AG, Gilead Sciences Inc., Novartis AG, TG Therapeutics Inc., Secura Bio, Inc.
製品セグメンテーションに関連する主要なトレンド, 企業の形成と市場シェア, 地理的フットプリントの分析
概要
このインサイトレポートは、グローバルなホスホイノシチド3キナーゼ阻害剤の状況を包括的に分析し、製品のセグメンテーション、会社の形成、収益、市場シェア、最新の発展、M&A活動に関連する重要なトレンドを強調しています。このレポートでは、ホスホイノシチド3キナーゼ阻害剤のポートフォリオと能力、市場参入戦略、市場ポジション、地理的な足跡に焦点を当て、業界のリーダーであるグローバル企業の戦略も分析し、急速に成長するグローバルなホスホイノシチド3キナーゼ阻害剤市場におけるこれらの企業のユニークなポジションをよりよく理解するための情報を提供します。
このインサイトレポートは、リン脂質インジストール-3キナーゼ阻害剤に関する重要な市場動向、推進要因、および影響要因を評価し、タイプ、用途、地域、そして市場規模ごとに予測を分解して新たな機会のポケットを強調します。数百のボトムアップの定性的および定量的市場インプットに基づいた透明な方法論を用いて、この研究の予測は、リン脂質インジストール-3キナーゼ阻害剤の現在の状態と将来の軌道に対して非常に詳細な見解を提供します。
グローバルファスフォイノシチド3キナーゼ阻害剤市場の規模は、2022年のXX米ドルから2029年のXX米ドルに成長すると予測されています。また、2023年から2029年にかけて、CAGRはXX%の成長が期待されています。
アメリカ合衆国のホスファチジルイノシトール3-キナーゼ阻害剤市場は、2022年のXX米ドルから2029年にはXX米ドルに増加すると推定され、2023年から2029年の間にXX%の年平均成長率（CAGR）で成長する見込みです。
中国におけるホスファチジルイノシトール3キナーゼ阻害剤市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年の間でXX%のCAGRを示す見込みです。
ヨーロッパのホスホイノシチド3キナーゼ阻害剤市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると見込まれ、2023年から2029年の間にXX%のCAGRで成長します。
グローバルな主要なホスホイノシチド3-キナーゼ阻害剤のプレーヤーには、バイエルAG、ギリアドサイエンシズ社、ノバルティスAG、TGセラピューティクス社、セキュラバイオ社などが含まれます。収益に関しては、2022年において、世界の2社がほぼXX%のシェアを占めました。
この報告書は、製品タイプ、アプリケーション、主要企業、主要地域および国別のホスファチジルイノシトール3キナーゼ阻害剤市場の包括的な概観、市場シェア、成長機会を示しています。
市場のセグメンテーション：
タイプ別セグメンテーション
パーンPI3K阻害剤
デュアル PI3K/mTOR 阻害剤
その他
用途別のセグメンテーション
CLL/SLL - 慢性リンパ球性白血病/小リンパ球性リンパ腫
濾胞性リンパ腫
その他の指標
このレポートは地域ごとに市場を分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から得られた情報や、企業のカバレッジ、製品ポートフォリオ、市場浸透率を分析した結果に基づいて選定されています。
バイエル社
ギリアド・サイエンシズ社
ノバルティスAG
TGセラピューティクス社
セキュラ・バイオ株式会社
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルのホスホイノシチド3キナーゼ阻害剤市場規模、（2018年～2029年）
2.1.2 ホスホイノシチド3キナーゼ阻害剤市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 ホスホイノシチド3キナーゼ阻害剤セグメント、タイプ別
2.2.1 汎PI3K阻害剤
2.2.2 デュアルPI3K/mTOR阻害剤
2.2.3 その他
2.3 ホスホイノシチド3キナーゼ阻害剤市場規模：タイプ別
2.3.1 ホスホイノシチド3キナーゼ阻害剤市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルのホスホイノシチド3キナーゼ阻害剤市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 ホスホイノシチド3キナーゼ阻害剤セグメント、用途別
2.4.1 CLL/SLL-慢性リンパ性白血病／小リンパ球性リンパ腫
2.4.2 濾胞性リンパ腫
2.4.3 その他の適応症
2.5 ホスホイノシチド3キナーゼ阻害剤市場規模：用途別
2.5.1 ホスホイノシチド3キナーゼ阻害剤市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルのホスホイノシチド3キナーゼ阻害剤市場規模、市場シェア（用途別）（2018年～2023年）
3 ホスホイノシチド3キナーゼ阻害剤市場規模：プレイヤー別
3.1 ホスホイノシチド3キナーゼ阻害剤市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおけるホスホイノシチド3キナーゼ阻害剤市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおけるホスホイノシチド3キナーゼ阻害剤市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルのホスホイノシチド3キナーゼ阻害剤市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 ホスホイノシチド3キナーゼ阻害剤、地域別
4.1 ホスホイノシチド3キナーゼ阻害剤市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおけるホスホイノシチド3キナーゼ阻害剤市場規模成長（2018年〜2023年）
4.3 APACにおけるホスホイノシチド3キナーゼ阻害剤市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおけるホスホイノシチド3キナーゼ阻害剤市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおけるホスホイノシチド3キナーゼ阻害剤市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおけるホスホイノシチド3キナーゼ阻害剤市場規模、国別（2018年〜2023年）
5.2 アメリカズにおけるホスホイノシチド3キナーゼ阻害剤市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおけるホスホイノシチド3キナーゼ阻害剤市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおけるホスホイノシチド3キナーゼ阻害剤市場規模、地域別（2018年〜2023年）
6.2 APACにおけるホスホイノシチド3キナーゼ阻害剤市場規模、タイプ別（2018年〜2023年）
6.3 APACにおけるホスホイノシチド3キナーゼ阻害剤市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパのホスホイノシチド3キナーゼ阻害剤 国別（2018年～2023年）
7.2 ヨーロッパにおけるホスホイノシチド3キナーゼ阻害剤市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおけるホスホイノシチド3キナーゼ阻害剤市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカのホスホイノシチド3キナーゼ阻害剤 地域別（2018年～2023年）
8.2 中東・アフリカにおけるホスホイノシチド3キナーゼ阻害剤市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおけるホスホイノシチド3キナーゼ阻害剤市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルのホスホイノシチド3キナーゼ阻害剤市場、市場予測
10.1 グローバルのホスホイノシチド3キナーゼ阻害剤、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルのホスホイノシチド3キナーゼ阻害剤、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズのホスホイノシチド3キナーゼ阻害剤、市場予測
10.1.3 APACのホスホイノシチド3キナーゼ阻害剤、市場予測
10.1.4 ヨーロッパのホスホイノシチド3キナーゼ阻害剤、市場予測
10.1.5 中東・アフリカのホスホイノシチド3キナーゼ阻害剤、市場予測
10.2 アメリカズのホスホイノシチド3キナーゼ阻害剤、市場予測（国別）（2024年～2029年）
10.3 APACのホスホイノシチド3キナーゼ阻害剤、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパのホスホイノシチド3キナーゼ阻害剤、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカのホスホイノシチド3キナーゼ阻害剤、市場予測（地域別）（2024年～2029年）
10.6 グローバルのホスホイノシチド3キナーゼ阻害剤、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルのホスホイノシチド3キナーゼ阻害剤、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 Bayer AG
11.1.1 Bayer AG：企業情報
11.1.2 Bayer AG：ホスホイノシチド3キナーゼ阻害剤分野の提供製品
11.1.3 Bayer AG：ホスホイノシチド3キナーゼ阻害剤収益・グロスマージンおよび市場シェア（2018年～2023年）
11.1.4 Bayer AG：主要事業概要
11.1.5 Bayer AG：直近の展開
11.2 Gilead Sciences Inc
11.3 Novartis AG
11.3.1 Novartis AG：企業情報
11.3.2 Novartis AG：ホスホイノシチド3キナーゼ阻害剤分野の提供製品
11.3.3 Novartis AG：ホスホイノシチド3キナーゼ阻害剤収益・グロスマージンおよび市場シェア（2018年～2023年）
11.3.4 Novartis AG：主要事業概要
11.3.5 Novartis AG：直近の展開
11.4 TG Therapeutics Inc
11.5 Secura Bio, Inc
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
This Insight Report provides a comprehensive analysis of the global Phosphoinositide 3-Kinase Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phosphoinositide 3-Kinase Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phosphoinositide 3-Kinase Inhibitor market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phosphoinositide 3-Kinase Inhibitor and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phosphoinositide 3-Kinase Inhibitor.
The global Phosphoinositide 3-Kinase Inhibitor market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Phosphoinositide 3-Kinase Inhibitor is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Phosphoinositide 3-Kinase Inhibitor is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Phosphoinositide 3-Kinase Inhibitor is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Phosphoinositide 3-Kinase Inhibitor players cover Bayer AG, Gilead Sciences Inc., Novartis AG, TG Therapeutics Inc. and Secura Bio, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Phosphoinositide 3-Kinase Inhibitor market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Pan-PI3K Inhibitors
Dual PI3K/mTOR inhibitors
Other
Segmentation by application
CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma
FL - Follicular Iymphoma
Other Indications
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer AG
Gilead Sciences Inc.
Novartis AG
TG Therapeutics Inc.
Secura Bio, Inc.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Phosphoinositide 3-Kinase Inhibitor Market Size 2018-2029
2.1.2 Phosphoinositide 3-Kinase Inhibitor Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Phosphoinositide 3-Kinase Inhibitor Segment by Type
2.2.1 Pan-PI3K Inhibitors
2.2.2 Dual PI3K/mTOR inhibitors
2.2.3 Other
2.3 Phosphoinositide 3-Kinase Inhibitor Market Size by Type
2.3.1 Phosphoinositide 3-Kinase Inhibitor Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type (2018-2023)
2.4 Phosphoinositide 3-Kinase Inhibitor Segment by Application
2.4.1 CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma
2.4.2 FL - Follicular Iymphoma
2.4.3 Other Indications
2.5 Phosphoinositide 3-Kinase Inhibitor Market Size by Application
2.5.1 Phosphoinositide 3-Kinase Inhibitor Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application (2018-2023)
3 Phosphoinositide 3-Kinase Inhibitor Market Size by Player
3.1 Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Players
3.1.1 Global Phosphoinositide 3-Kinase Inhibitor Revenue by Players (2018-2023)
3.1.2 Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Players (2018-2023)
3.2 Global Phosphoinositide 3-Kinase Inhibitor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Phosphoinositide 3-Kinase Inhibitor by Regions
4.1 Phosphoinositide 3-Kinase Inhibitor Market Size by Regions (2018-2023)
4.2 Americas Phosphoinositide 3-Kinase Inhibitor Market Size Growth (2018-2023)
4.3 APAC Phosphoinositide 3-Kinase Inhibitor Market Size Growth (2018-2023)
4.4 Europe Phosphoinositide 3-Kinase Inhibitor Market Size Growth (2018-2023)
4.5 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size Growth (2018-2023)
5 Americas
5.1 Americas Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2018-2023)
5.2 Americas Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2018-2023)
5.3 Americas Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2018-2023)
6.2 APAC Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2018-2023)
6.3 APAC Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Phosphoinositide 3-Kinase Inhibitor by Country (2018-2023)
7.2 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2018-2023)
7.3 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor by Region (2018-2023)
8.2 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2018-2023)
8.3 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.1 Global Phosphoinositide 3-Kinase Inhibitor Forecast by Regions (2024-2029)
10.1.1 Global Phosphoinositide 3-Kinase Inhibitor Forecast by Regions (2024-2029)
10.1.2 Americas Phosphoinositide 3-Kinase Inhibitor Forecast
10.1.3 APAC Phosphoinositide 3-Kinase Inhibitor Forecast
10.1.4 Europe Phosphoinositide 3-Kinase Inhibitor Forecast
10.1.5 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Forecast
10.2 Americas Phosphoinositide 3-Kinase Inhibitor Forecast by Country (2024-2029)
10.2.1 United States Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.2.2 Canada Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.2.3 Mexico Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.2.4 Brazil Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.3 APAC Phosphoinositide 3-Kinase Inhibitor Forecast by Region (2024-2029)
10.3.1 China Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.3.2 Japan Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.3.3 Korea Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.3.4 Southeast Asia Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.3.5 India Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.3.6 Australia Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.4 Europe Phosphoinositide 3-Kinase Inhibitor Forecast by Country (2024-2029)
10.4.1 Germany Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.4.2 France Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.4.3 UK Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.4.4 Italy Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.4.5 Russia Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.5 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Forecast by Region (2024-2029)
10.5.1 Egypt Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.5.2 South Africa Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.5.3 Israel Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.5.4 Turkey Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.5.5 GCC Countries Phosphoinositide 3-Kinase Inhibitor Market Forecast
10.6 Global Phosphoinositide 3-Kinase Inhibitor Forecast by Type (2024-2029)
10.7 Global Phosphoinositide 3-Kinase Inhibitor Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Bayer AG
11.1.1 Bayer AG Company Information
11.1.2 Bayer AG Phosphoinositide 3-Kinase Inhibitor Product Offered
11.1.3 Bayer AG Phosphoinositide 3-Kinase Inhibitor Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bayer AG Main Business Overview
11.1.5 Bayer AG Latest Developments
11.2 Gilead Sciences Inc.
11.2.1 Gilead Sciences Inc. Company Information
11.2.2 Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Product Offered
11.2.3 Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Gilead Sciences Inc. Main Business Overview
11.2.5 Gilead Sciences Inc. Latest Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Phosphoinositide 3-Kinase Inhibitor Product Offered
11.3.3 Novartis AG Phosphoinositide 3-Kinase Inhibitor Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novartis AG Main Business Overview
11.3.5 Novartis AG Latest Developments
11.4 TG Therapeutics Inc.
11.4.1 TG Therapeutics Inc. Company Information
11.4.2 TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Product Offered
11.4.3 TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 TG Therapeutics Inc. Main Business Overview
11.4.5 TG Therapeutics Inc. Latest Developments
11.5 Secura Bio, Inc.
11.5.1 Secura Bio, Inc. Company Information
11.5.2 Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Product Offered
11.5.3 Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Secura Bio, Inc. Main Business Overview
11.5.5 Secura Bio, Inc. Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Phosphoinositide 3-Kinase Inhibitor Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Pan-PI3K Inhibitors Table 3. Major Players of Dual PI3K/mTOR inhibitors Table 4. Major Players of Other Table 5. Phosphoinositide 3-Kinase Inhibitor Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 6. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2018-2023) & ($ Millions) Table 7. Global Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type (2018-2023) Table 8. Phosphoinositide 3-Kinase Inhibitor Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 9. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2018-2023) & ($ Millions) Table 10. Global Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application (2018-2023) Table 11. Global Phosphoinositide 3-Kinase Inhibitor Revenue by Players (2018-2023) & ($ Millions) Table 12. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Player (2018-2023) Table 13. Phosphoinositide 3-Kinase Inhibitor Key Players Head office and Products Offered Table 14. Phosphoinositide 3-Kinase Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Regions 2018-2023 & ($ Millions) Table 18. Global Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Regions (2018-2023) Table 19. Global Phosphoinositide 3-Kinase Inhibitor Revenue by Country/Region (2018-2023) & ($ millions) Table 20. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Country/Region (2018-2023) Table 21. Americas Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2018-2023) & ($ Millions) Table 22. Americas Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Country (2018-2023) Table 23. Americas Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2018-2023) & ($ Millions) Table 24. Americas Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type (2018-2023) Table 25. Americas Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2018-2023) & ($ Millions) Table 26. Americas Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application (2018-2023) Table 27. APAC Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2018-2023) & ($ Millions) Table 28. APAC Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Region (2018-2023) Table 29. APAC Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2018-2023) & ($ Millions) Table 30. APAC Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type (2018-2023) Table 31. APAC Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2018-2023) & ($ Millions) Table 32. APAC Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application (2018-2023) Table 33. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2018-2023) & ($ Millions) Table 34. Europe Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Country (2018-2023) Table 35. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2018-2023) & ($ Millions) Table 36. Europe Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type (2018-2023) Table 37. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2018-2023) & ($ Millions) Table 38. Europe Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application (2018-2023) Table 39. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2018-2023) & ($ Millions) Table 40. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Region (2018-2023) Table 41. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2018-2023) & ($ Millions) Table 42. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type (2018-2023) Table 43. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2018-2023) & ($ Millions) Table 44. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application (2018-2023) Table 45. Key Market Drivers & Growth Opportunities of Phosphoinositide 3-Kinase Inhibitor Table 46. Key Market Challenges & Risks of Phosphoinositide 3-Kinase Inhibitor Table 47. Key Industry Trends of Phosphoinositide 3-Kinase Inhibitor Table 48. Global Phosphoinositide 3-Kinase Inhibitor Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 49. Global Phosphoinositide 3-Kinase Inhibitor Market Size Market Share Forecast by Regions (2024-2029) Table 50. Global Phosphoinositide 3-Kinase Inhibitor Market Size Forecast by Type (2024-2029) & ($ Millions) Table 51. Global Phosphoinositide 3-Kinase Inhibitor Market Size Forecast by Application (2024-2029) & ($ Millions) Table 52. Bayer AG Details, Company Type, Phosphoinositide 3-Kinase Inhibitor Area Served and Its Competitors Table 53. Bayer AG Phosphoinositide 3-Kinase Inhibitor Product Offered Table 54. Bayer AG Phosphoinositide 3-Kinase Inhibitor Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 55. Bayer AG Main Business Table 56. Bayer AG Latest Developments Table 57. Gilead Sciences Inc. Details, Company Type, Phosphoinositide 3-Kinase Inhibitor Area Served and Its Competitors Table 58. Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Product Offered Table 59. Gilead Sciences Inc. Main Business Table 60. Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 61. Gilead Sciences Inc. Latest Developments Table 62. Novartis AG Details, Company Type, Phosphoinositide 3-Kinase Inhibitor Area Served and Its Competitors Table 63. Novartis AG Phosphoinositide 3-Kinase Inhibitor Product Offered Table 64. Novartis AG Main Business Table 65. Novartis AG Phosphoinositide 3-Kinase Inhibitor Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 66. Novartis AG Latest Developments Table 67. TG Therapeutics Inc. Details, Company Type, Phosphoinositide 3-Kinase Inhibitor Area Served and Its Competitors Table 68. TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Product Offered Table 69. TG Therapeutics Inc. Main Business Table 70. TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 71. TG Therapeutics Inc. Latest Developments Table 72. Secura Bio, Inc. Details, Company Type, Phosphoinositide 3-Kinase Inhibitor Area Served and Its Competitors Table 73. Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Product Offered Table 74. Secura Bio, Inc. Main Business Table 75. Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 76. Secura Bio, Inc. Latest Developments List of Figures Figure 1. Phosphoinositide 3-Kinase Inhibitor Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Phosphoinositide 3-Kinase Inhibitor Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Phosphoinositide 3-Kinase Inhibitor Sales Market Share by Country/Region (2022) Figure 8. Phosphoinositide 3-Kinase Inhibitor Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type in 2022 Figure 10. Phosphoinositide 3-Kinase Inhibitor in CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma Figure 11. Global Phosphoinositide 3-Kinase Inhibitor Market: CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma (2018-2023) & ($ Millions) Figure 12. Phosphoinositide 3-Kinase Inhibitor in FL - Follicular Iymphoma Figure 13. Global Phosphoinositide 3-Kinase Inhibitor Market: FL - Follicular Iymphoma (2018-2023) & ($ Millions) Figure 14. Phosphoinositide 3-Kinase Inhibitor in Other Indications Figure 15. Global Phosphoinositide 3-Kinase Inhibitor Market: Other Indications (2018-2023) & ($ Millions) Figure 16. Global Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application in 2022 Figure 17. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Player in 2022 Figure 18. Global Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Regions (2018-2023) Figure 19. Americas Phosphoinositide 3-Kinase Inhibitor Market Size 2018-2023 ($ Millions) Figure 20. APAC Phosphoinositide 3-Kinase Inhibitor Market Size 2018-2023 ($ Millions) Figure 21. Europe Phosphoinositide 3-Kinase Inhibitor Market Size 2018-2023 ($ Millions) Figure 22. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size 2018-2023 ($ Millions) Figure 23. Americas Phosphoinositide 3-Kinase Inhibitor Value Market Share by Country in 2022 Figure 24. United States Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 25. Canada Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 26. Mexico Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 27. Brazil Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 28. APAC Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Region in 2022 Figure 29. APAC Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type in 2022 Figure 30. APAC Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application in 2022 Figure 31. China Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 32. Japan Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 33. Korea Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 34. Southeast Asia Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 35. India Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 36. Australia Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 37. Europe Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Country in 2022 Figure 38. Europe Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type (2018-2023) Figure 39. Europe Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application (2018-2023) Figure 40. Germany Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 41. France Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 42. UK Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 43. Italy Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 44. Russia Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 45. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Region (2018-2023) Figure 46. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type (2018-2023) Figure 47. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application (2018-2023) Figure 48. Egypt Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 49. South Africa Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 50. Israel Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 51. Turkey Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 52. GCC Country Phosphoinositide 3-Kinase Inhibitor Market Size Growth 2018-2023 ($ Millions) Figure 53. Americas Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 54. APAC Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 55. Europe Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 56. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 57. United States Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 58. Canada Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 59. Mexico Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 60. Brazil Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 61. China Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 62. Japan Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 63. Korea Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 64. Southeast Asia Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 65. India Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 66. Australia Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 67. Germany Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 68. France Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 69. UK Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 70. Italy Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 71. Russia Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 72. Spain Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 73. Egypt Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 74. South Africa Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 75. Israel Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 76. Turkey Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 77. GCC Countries Phosphoinositide 3-Kinase Inhibitor Market Size 2024-2029 ($ Millions) Figure 78. Global Phosphoinositide 3-Kinase Inhibitor Market Size Market Share Forecast by Type (2024-2029) Figure 79. Global Phosphoinositide 3-Kinase Inhibitor Market Size Market Share Forecast by Application (2024-2029)
